(Q35214052)

7 August 2017

1 reference

title

Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone (English)

1 reference

7 August 2017

Karl T Weber

1

1 reference

7 August 2017

1 August 2003

1 reference

7 August 2017

Translational Research

1 reference

7 August 2017

142

1 reference

7 August 2017

2

1 reference

7 August 2017

71-82

1 reference

The correspondence of S.A.S. Simpson and J.F. Tait with T. Reichstein during their collaborative work on the isolation and elucidation of the structure of electrocortin (later aldosterone).

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

The general adaptation syndrome and the diseases of adaptation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Mechanisms of salt and water retention in congestive heart failure. The importance of aldosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Action of new steroids in blocking effects of aldosterone and desoxycorticosterone on salt.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

7 January 2021

Aldosterone antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Mode of action and clinical usefulness of aldosterone antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Heart-hitting tales of salt and destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Aldosterone in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Nongenomic effects of aldosterone: cellular aspects and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Spontaneous hypopotassemia, hypomagnesemia, alkalosis and tetany due to hypersecretion of corticosterone-like mineralocorticoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

The occurrence of electrocortin in human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Adrenal cortical carcinoma producing solely mineralocorticoid effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Primary aldosteronism due to adrenocortical hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Adrenocortical tumour with hypokalaemia and flaccid muscle paralysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Conn's syndrome with severe hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Effect of aldosterone on the metabolism of magnesium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Studies on the combined use of measurements of sweat electrolyte composition and rate of sweating as an index of adrenal cortical activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Aldosterone excretion in acclimatization to heat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Excretion of Sodium, Potassium, Magnesium and Iron in Human Sweat and the Relation of Each to Balance and Requirements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Aldosterone and oxidative phosphorylation in liver mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Comparative effects of aldosterone and heat acclimatization on oxidative enzymes in rat tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

ELECTROLYTE BALANCE STUDIES IN ADRENALECTOMIZED DOGS WITH PARTICULAR REFERENCE TO THE EXCRETION OF SODIUM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

STUDIES ON THE SUPRARENAL CORTEX : III. PLASMA ELECTROLYTES AND ELECTROLYTE EXCRETION DURING SUPRARENAL INSUFFICIENCY IN THE DOG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

The influence of adrenalectomy on muscle constituents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Effect of various adrenal steroids on plasma magnesium and the electrocardiogram of adrenalectomized dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

The influence of aldosterone on magnesium metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Aldosterone receptors in different types of primary hyperaldosteronism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Regulation of aldosterone receptors in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Intralymphocyte free magnesium in patients with primary aldosteronism: aldosterone and lymphocyte magnesium homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Regulation of cellular magnesium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Aldosterone Secretion in Magnesium-Deficient Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

The effect of magnesium deficiency on serum aldosterone in rats fed two levels of sodium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Magnesium deficiency produces insulin resistance and increased thromboxane synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Magnesium ion: a possible physiological regulator of aldosterone production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

The production of secondary potassium depletion, sodium retention, nephrocalcinosis and hypercalcaemia by magnesium deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Myocardial K kinetics in rats on Mg-deficient diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Remodeling of the rat right and left ventricles in experimental hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Protection by a Steroid-Spirolactone Against Certain Types of Cardiac Necroses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Aldosterone-induced inflammation in the rat heart : role of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Effect of acute magnesium deficiency (MgD) on aortic endothelial cell (EC) oxidant production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Enhanced NO production during Mg deficiency and its role in mediating red blood cell glutathione loss.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Vasodilation to acetylcholine in primary and secondary forms of human hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Idiopathic intracranial hypertension with primary aldosteronism: report of 2 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Pseudotumor cerebri in a patient with Bartter's syndrome and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Aldosterone biosynthesis in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Extra-adrenal mineralocorticoids and cardiovascular tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Molecular mechanisms of myocardial remodeling. The role of aldosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Benign forms of intracranial hypertension; toxic and otitic hydrocephalus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Disturbance of pituitary-adrenal interrelationships in benign intracranial hypertension (pseudotumor cerebri).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

BENIGN INTRACRANIAL HYPERTENSION. VI. OBESITY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Localization of aldosterone and corticosterone in the central nervous system, assessed by quantitative autoradiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

NA-K ACTIVATED ADENOSINE TRIPHOSPHATASE FORMATION OF CEREBROSPINAL FLUID IN THE CAT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Active transport of sodium and potassium by the choroid plexus of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Corticosteroid receptors in cells derived from rat brain microvessels: mRNA identification and aldosterone binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Effects of Pco2 acetazolamide and ouabain on volume and composition of choroid-plexus fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

The effects of some inhibitors and accelerators of sodium transport on the turnover of22Na in the cerebrospinal fluid and the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Cytochemical study on enzyme activity associated with cerebrospinal fluid secretion in the choroid plexus and ventricular ependyma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

The effects of hypo- and hyperkalemia on choroid plexus potassium transport.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Intracerebroventricular infusion of aldosterone induces hypertension in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Hormonal actions of the heart and of lungs on the isolated kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

The isolation of a substance very closely resembling the 18-monoacetate of D-aldosterone from the venous blood of activated muscle and from contracting muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Changes in the flow and composition of the urine induced by the 18 monoacetate of D-aldosterone, in cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

The influence of heart rate on the secretion of a substance closely resembling the 18-monoacetate of D-aldosterone by the hearts of cats under chloralose anaesthesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Factors controlling the secretion of a substance biologically resembling the 18-monoacetate of D-aldosterone by heart muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

The isolation of a renally active substance from arterial blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Production of aldosterone in isolated rat blood vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Aldosterone production is activated in failing ventricle in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

High affinity NAD(+)-dependent 11 beta-hydroxysteroid dehydrogenase in the human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Regional changes in angiotensin II receptor density after experimental myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Cardiac aldosterone production and ventricular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarctio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

Effects of aldosterone on the urinary excretion of total and non-dialyzable hydroxyproline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Presence of aldosterone-like immunoreactivity in cerebrospinal fluid in normotensive subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Hypertensive mechanisms associated with centrally administered aldosterone in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900062-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-2143(03)00062-3

1 reference

7 August 2017

1 reference

PubMed ID

12960953